Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C MutationFerdinandos Skoulidis, Ramaswamy Govindan, Bob T. Li et al.|New England Journal of Medicine|2021Cited by 1.8k
Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung CancerBob T. Li, Pasi A. Jänne|New England Journal of Medicine|2021Cited by 949
First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK Mutant Advanced Solid Tumors: Results of a Phase I Dose-Escalation and Expansion StudyRyan J. Sullivan, Bob T. Li, Richard D. Carvajal et al.|Cancer Discovery|2017Cited by 418
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic SarcomasNatasha Rekhtman, William D. Travis, Joseph Montecalvo et al.|Journal of Thoracic Oncology|2019Cited by 307
Inferring gene expression from cell-free DNA fragmentation profilesMohammad Shahrokh Esfahani, Ash A. Alizadeh, Emily G. Hamilton et al.|Nature Biotechnology|2022Cited by 213